Minimum Necessary Use and Disclosure Sample Clauses

The Minimum Necessary Use and Disclosure clause restricts the use and sharing of protected information to only what is essential for a specific purpose. In practice, this means that when handling sensitive data—such as personal health information—parties must limit access and disclosure to the smallest amount needed to accomplish a task, and only authorized individuals should be involved. This clause helps protect privacy by reducing unnecessary exposure of confidential information and ensures compliance with data protection regulations.
Minimum Necessary Use and Disclosure. In conducting functions and/or activities under the Services Agreement and this Agreement that involve the use and/or disclosure of PHI, Business Associate shall make reasonable efforts to limit the use and/or disclosure of PHI to the minimum amount of information necessary as determined by Covered Entity to accomplish the intended purpose of the use or disclosure.
View SourceView Similar (6)
Minimum Necessary Use and Disclosure. Business Associate shall make reasonable efforts to limit the use and disclosure of, and request for, Protected Health Information to the minimum amount of information necessary to accomplish the intended purpose of the use, disclosure, or request, subject to any applicable exceptions under the HIPAA Privacy Regulations.
View SourceView Similar (4)
Minimum Necessary Use and Disclosure. Business Associate will determine the amount of PHI necessary for performance of the Service and will make reasonable efforts to limit the receipt, use, and disclosure of PHI to the minimum necessary as required by Privacy Laws.
View SourceView Similar (3)
Minimum Necessary Use and Disclosure. If Seller uses, discloses or requests PHI in accordance with this Business Associate Agreement or as required by law, Seller shall do so in a manner consistent with MetroHealth policies and procedures regarding the minimum necessary use and disclosure of PHI.
View SourceView Similar (2)
Minimum Necessary Use and Disclosure. If Business Associate uses, discloses or requests PHI in accordance with the Agreement or as required by law, Business Associate shall do so in a manner consistent with MetroHealth policies and procedures regarding the minimum necessary use and disclosure of PHI.
View SourceView Similar (2)
Minimum Necessary Use and Disclosure. In conducting its functions and activities under this Agreement involving the use and disclosure of PHI, Subcontractor shall make reasonable efforts to limit the use and disclosure of PHI to the minimum necessary to accomplish the intended purpose of the use or disclosure as described in 45 C.F.R. § 164.514(d).
View Source
Minimum Necessary Use and Disclosure. In accordance with the HIPAA Rules, when using or disclosing Protected Health Information, or when requesting PHI from Covered Entity or another covered entity or business associate, Business Associate agrees to make reasonable efforts to limit the PHI to the minimum necessary to accomplish the intended purpose of the use, disclosure or request.
View Source
Minimum Necessary Use and Disclosure. Covered Entity shall make reasonable efforts to limit the disclosure of PHI to the minimum necessary to accomplish the intended purpose of the use or disclosure as required by the Privacy Rule.
View Source

Related to Minimum Necessary Use and Disclosure

  • Use and Disclosure All Confidential Information of a party will be held in confidence by the other party with at least the same degree of care as such party protects its own confidential or proprietary information of like kind and import, but not less than a reasonable degree of care. Neither party will disclose in any manner Confidential Information of the other party in any form to any person or entity without the other party’s prior consent. However, each party may disclose relevant aspects of the other party’s Confidential Information to its officers, affiliates, agents, subcontractors and employees to the extent reasonably necessary to perform its duties and obligations under this Agreement and such disclosure is not prohibited by applicable law. Without limiting the foregoing, each party will implement physical and other security measures and controls designed to protect (a) the security and confidentiality of Confidential Information; (b) against any threats or hazards to the security and integrity of Confidential Information; and (c) against any unauthorized access to or use of Confidential Information. To the extent that a party delegates any duties and responsibilities under this Agreement to an agent or other subcontractor, the party ensures that such agent and subcontractor are contractually bound to confidentiality terms consistent with the terms of this Section 11.

  • Permitted Use and Disclosures Each Party hereto may use or disclose Confidential Information disclosed to it by the other Party to the extent such information is included in the Pharmacopeia Technology, Schering Technology or Collaboration Technology, as the case may be, and to the extent (i) such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder in filing or prosecuting patent applications, prosecuting or defending litigation, (ii) such disclosure is reasonably required to be made to any institutional review board of any entity conducting clinical trials with Agreement Compound(s) and/or Agreement Product(s), or to any governmental or other regulatory agency, in order to gain approval to conduct clinical trials or to market Agreement Compound(s) and/or Agreement Products, (iii) such disclosure is required by law, regulation, rule, act or order of any governmental authority, court, or agency, or is made in connection with submitting required information to tax or other governmental authorities, or (iv) such disclosure or use is reasonably required in conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted to it by the other Party pursuant to the terms of this Agreement; in each case, provided that if a Party is required to make any such disclosure of another Party’s Confidential Information, other than pursuant to a confidentiality agreement, it will give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of patent applications, will use its reasonable diligent efforts to secure confidential treatment of such Confidential Information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

  • Specific Use and Disclosure Provisions (A) Except as otherwise limited in this Section of the Contract, Business Associate may use PHI for the proper management and administration of Business Associate or to carry out the legal responsibilities of Business Associate. (B) Except as otherwise limited in this Section of the Contract, Business Associate may disclose PHI for the proper management and administration of Business Associate, provided that disclosures are Required by Law, or Business Associate obtains reasonable assurances from the person to whom the information is disclosed that it will remain confidential and used or further disclosed only as Required by Law or for the purpose for which it was disclosed to the person, and the person notifies Business Associate of any instances of which it is aware in which the confidentiality of the information has been breached. (C) Except as otherwise limited in this Section of the Contract, Business Associate may use PHI to provide data aggregation services to Covered Entity as permitted by 45 C.F.R. § 164.504(e)(2)(i)(B).

  • Restrictions on Use and Disclosure Covered Entity shall notify Business Associate of any restriction on the use or disclosure of PHI that Covered Entity has agreed to in accordance with 45 C.F.R. § 164.522, to the extent such restriction may affect Business Associate’s use or disclosure of PHI.

  • Use and Disclosure of PHI Business Associate is limited to the following permitted and required uses or disclosures of PHI: a. Duty to Protect PHI. Business Associate shall protect PHI from, and shall use appropriate safeguards, and comply with Subpart C of 45 CFR Part 164 (Security Standards for the Protection of Electronic Protected Health Information) with respect to EPHI, to prevent the unauthorized Use or disclosure of PHI other than as provided for in this Contract or as required by law, for as long as the PHI is within its possession and control, even after the termination or expiration of this Contract.